BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 11339521)

  • 1. Meloxicam: a review of its pharmacokinetics, efficacy and tolerability following intramuscular administration.
    Euller-Ziegler L; Vélicitat P; Bluhmki E; Türck D; Scheuerer S; Combe B
    Inflamm Res; 2001 Mar; 50 Suppl 1():S5-9. PubMed ID: 11339521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of intramuscular and oral meloxicam in rheumatoid arthritis patients.
    Combe B; Vélicitat P; Garzón N; Bluhmki E
    Inflamm Res; 2001 Mar; 50 Suppl 1():S10-6. PubMed ID: 11339515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of intramuscular and oral meloxicam in patients with acute lumbago: a comparison with intramuscular and oral piroxicam.
    Bosch HC; Sigmund R; Hettich M
    Curr Med Res Opin; 1997; 14(1):29-38. PubMed ID: 9524791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability of multiple administration of intramuscular meloxicam: a comparison with intramuscular piroxicam in patients with rheumatoid arthritis or osteoarthritis.
    Ghozlan PR; Bernhardt M; Vélicitat P; Bluhmki E
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():51-5. PubMed ID: 8630638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meloxicam oral suspension: a treatment alternative to solid meloxicam formulations.
    Hanft G; Türck D; Scheuerer S; Sigmund R
    Inflamm Res; 2001 Mar; 50 Suppl 1():S35-7. PubMed ID: 11339520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the onset and intensity of action of intramuscular meloxicam and oral meloxicam in patients with acute sciatica.
    Auvinet B; Ziller R; Appelboom T; Velicitat P
    Clin Ther; 1995; 17(6):1078-98. PubMed ID: 8750399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of meloxicam after intravenous, intramuscular, and oral administration of a single dose to Hispaniolan Amazon parrots (Amazona ventralis).
    Molter CM; Court MH; Cole GA; Gagnon DJ; Hazarika S; Paul-Murphy JR
    Am J Vet Res; 2013 Mar; 74(3):375-80. PubMed ID: 23438111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of 3 formulations of meloxicam in cynomolgus macaques (Macaca fascicularis).
    Bauer C; Frost P; Kirschner S
    J Am Assoc Lab Anim Sci; 2014 Sep; 53(5):502-11. PubMed ID: 25255073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and tolerability of meloxicam after i.m. administration.
    Narjes H; Türck D; Busch U; Heinzel G; Nehmiz G
    Br J Clin Pharmacol; 1996 Feb; 41(2):135-9. PubMed ID: 8838440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and safety of single and multiple oral doses of meloxicam in adult horses.
    Noble G; Edwards S; Lievaart J; Pippia J; Boston R; Raidal SL
    J Vet Intern Med; 2012; 26(5):1192-201. PubMed ID: 22860573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic behavior of meloxicam in loggerhead sea turtles (Caretta caretta) after intramuscular and intravenous administration.
    Lai OR; Di Bello A; Soloperto S; Freggi D; Marzano G; Cavaliere L; Crescenzo G
    J Wildl Dis; 2015 Apr; 51(2):509-12. PubMed ID: 25647596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Meloxicam: intramuscular administration in rheumatology].
    Tsvetkova ES
    Ter Arkh; 2003; 75(8):96-7. PubMed ID: 14520864
    [No Abstract]   [Full Text] [Related]  

  • 13. Local tissue tolerability of meloxicam, a new NSAID: indications for parenteral, dermal and mucosal administration.
    Stei P; Kruss B; Wiegleb J; Trach V
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():44-50. PubMed ID: 8630637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and tolerability of an 8-day administration of intravenous and oral meloxicam: a comparison with intramuscular and oral diclofenac in patients with acute lumbago. German Meloxicam Ampoule Study Group.
    Colberg K; Hettich M; Sigmund R; Degner FL
    Curr Med Res Opin; 1996; 13(7):363-77. PubMed ID: 8862936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High response rate in the phase I/II study of meloxicam in juvenile rheumatoid arthritis.
    Foeldvari I; Burgos-Vargas R; Thon A; Tuerck D
    J Rheumatol; 2002 May; 29(5):1079-83. PubMed ID: 12022326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rheumatic disease therapy without regret. Meloxicam dosage safety].
    MMW Fortschr Med; 2002 Nov; 144(46):66-7. PubMed ID: 12534086
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics of meloxicam after intramuscular and oral administration of a single dose to American flamingos (Phoenicopertus ruber).
    Boonstra JL; Cox SK; Martin-Jimenez T
    Am J Vet Res; 2017 Mar; 78(3):267-273. PubMed ID: 28240949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meloxicam in acute episodes of soft-tissue rheumatism of the shoulder.
    Vidal L; Kneer W; Baturone M; Sigmund R
    Inflamm Res; 2001 Mar; 50 Suppl 1():S24-9. PubMed ID: 11339517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral meloxicam is effective in acute sciatica: two randomised, double-blind trials versus placebo or diclofenac.
    Dreiser RL; Le Parc JM; Vélicitat P; Lleu PL
    Inflamm Res; 2001 Mar; 50 Suppl 1():S17-23. PubMed ID: 11339516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics of meloxicam. A cyclo-oxygenase-2 preferential nonsteroidal anti-inflammatory drug.
    Davies NM; Skjodt NM
    Clin Pharmacokinet; 1999 Feb; 36(2):115-26. PubMed ID: 10092958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.